Latest Posts
About This Stock
More About This Stock
Read
Read
Read
J&J's Kenvue Jumps 20% In Market Debut
Article By:
The Fly
Sunday, May 7, 2023 1:20 PM EDT
Shares of Johnson & Johnson's consumer-health spin-off Kenvue soared 20% in their market debut on Thursday, making it the biggest U.S. IPO in over a year. Under Kenvue's umbrella are widely-known consumer brands like Band-Aid, Tylenol, and Aveeno.
Johnson & Johnson Increases Dividend: What Shareholders Need To Know
Article By:
SureDividend
Wednesday, May 3, 2023 12:05 PM EDT
Johnson & Johnson recently raised its dividend by 5%, and thus it has now raised its dividend for 61 consecutive years.
In this article: JNJ
Johnson & Johnson Earnings: JNJ Breaks Above Resistance Following Q1 Beat, Targets $180
Article By:
FXStreet
Tuesday, April 18, 2023 8:02 AM EDT
Johnson & Johnson stock rose 2% in Tuesday's premarket after the healthcare and consumer goods conglomerate reported first-quarter adjusted earnings per share (EPS) of $2.68, 18 cents above Wall Street analysts' projections.
In this article: JNJ
Warren Buffett Stocks: Johnson & Johnson
#Buffett...Buffett...Buffett...loss Billions in oil...Apple lately.,...so?!
And $JNJ is way overbought.
It's Good To Be A Guinea Pig
It's crazy that they suspended the $JNJ vaccine because 6 people out of 7 million experience some adverse effects which did not even kill them. Meanwhile Covid has killed millions. Being that the JNJ vaccine had zero adverse effects in men, they should at least let me continue to get it. It's so hard to get vaccinated as is it.
How To Invest In Woman-Led Companies With ETFs & Stocks
Not until they remove cancer causing $JNJ from portfolio.
Johnson & Johnson: Recession Safety, Growth And Valuation
Inventors, do not trust johnson and Johnson $JNJ
Johnson & Johnson Upgraded To Neutral From Sell At Goldman Sachs
Still not impressed with $JNJ.